Key result
TRPC6 inhibition suppresses vasodilation and drives mesenteric constriction in aged but not young mice.
Why the study?
TRP cation channels play a crucial role in maintaining normal blood pressure and flow, motivating an investigation of whether TRPC6-mediated Ca2+ influx promotes sarcoplasmic reticulum Ca2+ refilling and RyR Ca2+ sparks to activate BKCa channels and limit myogenic arterial tone during aging.
Does CaMKIIδ-mediated TRPC6 activation promote RyR-BKCa feedback signaling to limit myogenic arterial tone in aging arteries?
Does CaMKIIδ-mediated TRPC6 activation promote RyR-BKCa feedback signaling to limit myogenic arterial tone in aging arteries?
Identifies age-dependent CaMKIIδ upregulation and subsequent TRPC6 membrane trafficking as a compensatory vasodilatory mechanism via RyR-BKCa signaling in aging resistance arteries.
Answers are grounded in this paper and cite their sources.
TRPC6 inhibition may enhance myogenic tone selectively in aging arteries; leaves open translation to human vascular disease.
BACKGROUND: TRP (transient receptor potential) cation channels play a crucial role in maintaining normal blood pressure and flow. We hypothesize that, during aging, TRPC6 (transient receptor potential cation channel subfamily C member 6)–mediated Ca 2+ influx promotes sarcoplasmic reticulum Ca 2+ refilling and RyR (ryanodine receptor) Ca 2+ sparks, thereby activating BK Ca (large-conductance Ca 2+ -activated K + ) channels to limit myogenic arterial tone. METHODS: Using vascular smooth muscle cells (VSMCs) from resistance-sized small mesenteric arteries, we tested selective TRPC6 inhibitors (SH045 and SAR7334) and smooth muscle–specific TRPC6 knockout mice. Ca 2+ sparks, BK Ca currents, and myogenic tone were measured in young (3–4 months) and old (12–14 months) mice. CaMKIIδ (Ca 2+ /calmodulin-dependent protein kinase IIδ) signaling was assessed pharmacologically and with a proteolysis-targeting chimera peptide degrader targeting CaMKIIδ. RESULTS: Inhibiting TRPC6 with SH045 or SAR7334 suppressed RyR-mediated Ca 2+ spark generation in VSMCs from old mice but not young mice. Similar results were found in smooth muscle–specific TRPC6 knockout mice. SH045 or SAR7334 also suppressed BK Ca currents and elicited constriction in mesenteric arteries from old mice. These effects were due to increased translocation of TRPC6 channels to the VSMC plasma membrane, mediated by CaMKIIδ signaling. Using a proteolysis-targeting chimera peptide degrader targeting CaMKIIδ, we demonstrated the impact of CaMKIIδ on TRPC6 externalization and RyR activation in old VSMCs. CONCLUSIONS: Together, our findings identify age-dependent CaMKIIδ upregulation as a key regulator of TRPC6 membrane trafficking, thereby indirectly enhancing RyR-BKCa signaling through sarcoplasmic reticulum Ca 2+ handling and promoting VSMC hyperpolarization and vasodilation in aging.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied Vascular aging (myogenic arterial tone in aging arteries). Selective TRPC6 inhibitors (SH045 and SAR7334), smooth muscle-specific TRPC6 knockout, and a proteolysis-targeting chimera peptide degrader targeting CaMKIIδ vs. Young mice (3–4 months) or untreated/wild-type controls was evaluated on RyR-mediated Ca2+ sparks, BKCa currents, and myogenic arterial tone. Inhibiting TRPC6 with SH045 or SAR7334 suppressed RyR-mediated Ca2+ sparks and BKCa currents, eliciting constriction in mesenteric arteries from old (12-14 months) but not young (3-4 months) mice.
Synapse has enriched 10 related papers. Consider them for comparative context: